Contact this trialFirst, we need to learn more about you.
Somatostatin Analogue
CAM2029 for Polycystic Liver Disease
Recruiting0 awardsPhase 2 & 3
Dallas, Texas
This trial is testing a new treatment for PLD, which is a condition that can cause problems with the liver. The new treatment is being compared to a placebo, and participants will be randomly assigned to one of three groups. The trial will last for 53 weeks, and participants may then choose to continue treatment for an additional 24 weeks.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service